Journal of Urologic Oncology

Declaration of Conflict of Interest for Editorial Board Members’ Articles: Editorial Office, Korean Urological Oncology Society; Journal of Urologic Oncology. 2024;22(1):95-96. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.2024.err01
Corrects: J Urol Oncol 2023;21(1):5
Corrects: J Urol Oncol 2023;21(1):14
Corrects: J Urol Oncol 2023;21(1):23
Corrects: J Urol Oncol 2023;21(1):53
Corrects: J Urol Oncol 2023;21(1):59
Corrects: J Urol Oncol 2023;21(1):79
Corrects: J Urol Oncol 2023;21(2):140; Full text PubReader ePub PDF

Bladder Cancer

Poorer Outcomes in Bladder Cancer Patients With Diabetes: A Systematic Review and Meta-analysis Addressing Over 226,472 Bladder Cancer Patients: Stefani Frost, Parisa Ziarati, Ryan Moen, Lynn Kysh, Robert Johnson, Shane Pearce, Siamak Daneshmand, Kimberly D. Siegmund, Victoria K. Cortessis; Journal of Urologic Oncology. 2024;22(1):78-94. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600020001
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Nephron-Sparing Surgery for Upper Urinary Tract Urothelial Carcinoma: Sung Han Kim, Ilma S. Savul, Seth P. Lerner; Journal of Urologic Oncology. 2024;22(1):68-77. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600180009
Cited By 1; Full text PubReader ePub PDF

Kidney Cancer

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study: Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):59-67. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600660033
Cited By 1; Full text PubReader ePub PDF

Prognostic Factors and Cancer-Specific Survival of Surgically Managed Renal Cell Carcinoma With Venous Thrombus: A 30-Year Experience at a Tertiary Referral Center: Hyun Young Lee, Yunjoong Kim, Bumjin Lim, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, Jungyo Suh; Journal of Urologic Oncology. 2024;22(1):52-58. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.234600600030
Cited By 1; Full text PubReader ePub PDF

Global Renal Cell Carcinoma Research Trends Over 30 Years: A PRISMA-Compliant Bibliometric Analysis: Jung Hoon Kim, Ji Woong Hwang; Journal of Urologic Oncology. 2024;22(1):42-51. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600120006
Cited By 1; Full text PubReader ePub PDF

Targeted Therapy Following Metastasectomy for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-analysis: Hui Mo Gu, Seung Il Jung, Dongdeuk Kwon, Myung Ha Kim, Jae Hung Jung, Mi Ah Han, Seung Hwan Lee, In Gab Jeong, Sun Il Kim, Eu Chang Hwang; Journal of Urologic Oncology. 2024;22(1):34-41. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600140007
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Prostate Cancer

Enzalutamide Maintenance Following Docetaxel in Metastatic Castration-Naive Prostate Cancer: A Pilot Feasibility Study: Sung Hee Lim, Sung Wook Cho, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Se Hoon Park; Journal of Urologic Oncology. 2024;22(1):29-33. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600040002
Cited By 1; Full text PubReader ePub PDF

High-Grade Late Urinary Toxicity Following Salvage Radiotherapy After Radical Prostatectomy: A Retrospective Cohort Study: Seung-Kwon Choi, Myong Kim, Sang Mi Lee, Cheryn Song, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn; Journal of Urologic Oncology. 2024;22(1):21-28. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600080004
Cited By 1; Full text PubReader ePub PDF

Multidisciplinary Team Approach in Prostate-Specific Membrane Antigen Theranostics for Prostate Cancer: A Narrative Review: Minseok Suh, Gi Jeong Cheon; Journal of Urologic Oncology. 2024;22(1):11-20. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600200010
Cited By 1; Full text PubReader ePub PDF

Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review: Chang Wook Jeong; Journal of Urologic Oncology. 2024;22(1):4-10. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.244600220011
Cited By 1; Full text PubReader ePub PDF

JUO, the Journal of Urologic Oncology, Celebrates Its Second Anniversary: Cheol Kwak; Journal of Urologic Oncology. 2024;22(1):1-3. Published online March 31, 2024; DOI: https://doi.org/10.22465/juo.24edi001; Full text PubReader ePub PDF

Clinical Significance of Rab27a as a Urinary Biomarker in Patients With Bladder Cancer: Ja Yoon Ku, Md Nazmul Huda, Eu Chang Hwang, Chan Ho Lee, Kyung Hwan Kim, Dong Deuk Kwon, Hong Koo Ha; Journal of Urologic Oncology. 2023;21(3):277-277. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.err.kjuo.2022.20.1.52
Corrects: J Urol Oncol 2022;20(1):52; Full text PubReader ePub PDF

Clinical Predictors of ARTA Response in Metastatic Prostate Cancer

Negative Delta-Prostate-Specific Antigen Time Ratio as Potential New Marker of Progression-Free Survival in Castration-Resistant Prostate Cancer Patients Treated With First-Line Enzalutamide or Docetaxel: Tae Hwan Kim, Seol Ho Choo, Kang Hee Shim, Sun Il Kim; Journal of Urologic Oncology. 2023;21(3):271-276. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600440022
Cited By 1; Full text PubReader ePub PDF

Nonregional Lymph Node Metastasis as a Predictor of Early Progression When Using Androgen Receptor Targeting Agents in Patients With Metastatic Castration-Resistant Prostate Cancer Without Previous Chemotherapy: Sihyeon Kim, Beom Yong Rho, Dong Hyuk Kang, Doo Yong Chung; Journal of Urologic Oncology. 2023;21(3):264-270. Published online November 30, 2023; DOI: https://doi.org/10.22465/juo.234600520026
Cited By 1; Full text PubReader ePub PDF

4,542	New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
4,204	The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
3,718	The Present and Future of Intravesical Therapy in Bladder Cancer
3,452	Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
3,199	Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?

Cited By 6	Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By 3	An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By 2	Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By 2	Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By 2	Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma

Search